Delivery Order SPE2DB24D1034-SPE2DB26FVXZ1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,980.28 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 23, 2025. The award was issued on September 22, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $14,087.43 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials on September 22, 2025, with completion scheduled for September 23, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle active through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,819.97 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, awarded on October 15, 2025, with a completion date of October 16, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $114,066.75 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $30,288.15 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $46,093.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $31,587.25 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $75,199.20 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $19,427.80 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $41,046.84 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 28, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB26FVXZ1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,178.18 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 17, 2025, and was awarded on October 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's comprehensive federal contracting portfolio demonstrates consistent delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This competitively awarded delivery order for the diabetes medication Ozempic exemplifies AmerisourceBergen's role as a prime pharmaceutical vendor supporting Department of Defense healthcare requirements through flexible contract vehicles that enable efficient procurement of essential medical commodities for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 10/16/25 |